Pittaluga Anna, Feligioni Marco, Longordo Fabio, Luccini Elisa, Raiteri Maurizio
Department of Experimental Medicine, Pharmacology and Toxicology Section, University of Genoa, Viale Cembrano 4, 16148 Genova, Italy.
Neuropharmacology. 2006 Mar;50(3):286-96. doi: 10.1016/j.neuropharm.2005.09.004. Epub 2005 Oct 19.
Postsynaptic glutamate AMPA receptors (AMPARs) can recycle between plasma membrane and intracellular pools. In contrast, trafficking of presynaptic AMPARs has not been investigated. AMPAR surface expression involves interactions between the GluR2 carboxy tail and various proteins including glutamate receptor-interacting protein (GRIP), AMPA receptor-binding protein (ABP), protein interacting with C kinase 1 (PICK1), N-ethyl-maleimide-sensitive fusion protein (NSF). Here, peptides known to selectively block the above interactions were entrapped into synaptosomes to study the effects on the AMPA-evoked release of [3H]noradrenaline ([3H]NA) and [3H]acetylcholine ([3H]ACh) from rat hippocampal and cortical synaptosomes, respectively. Internalization of pep2-SVKI to prevent GluR2-GRIP/ABP/PICK1 interactions potentiated the AMPA-evoked release of [3H]NA but left unmodified that of [3H]ACh. Similar potentiation was caused by pep2-AVKI, the blocker of GluR2-PICK1 interaction. Conversely, a decrease in the AMPA-evoked release of [3H]NA, but not of [3H]ACh, was caused by pep2m, a selective blocker of the GluR2-NSF interaction. In the presence of pep2-SVKI the presynaptic AMPARs on noradrenergic terminals lost sensitivity to cyclothiazide. AMPARs releasing [3H]ACh, but not those releasing [3H]NA, were sensitive to spermine, suggesting that they are GluR2-lacking AMPARs. To conclude: (i) release-regulating presynaptic AMPARs constitutively cycle in isolated nerve terminals; (ii) the process exhibits neuronal selectivity; (iii) AMPAR trafficking and desensitization may be interrelated.
突触后谷氨酸α-氨基-3-羟基-5-甲基-4-异恶唑丙酸受体(AMPARs)可在质膜和细胞内池之间循环。相比之下,突触前AMPARs的运输尚未得到研究。AMPAR的表面表达涉及GluR2羧基末端与多种蛋白质之间的相互作用,这些蛋白质包括谷氨酸受体相互作用蛋白(GRIP)、AMPA受体结合蛋白(ABP)、与C激酶1相互作用的蛋白(PICK1)、N-乙基马来酰亚胺敏感融合蛋白(NSF)。在此,将已知能选择性阻断上述相互作用的肽包裹在突触小体中,以分别研究其对大鼠海马和皮质突触小体中AMPA诱发的[3H]去甲肾上腺素([3H]NA)和[3H]乙酰胆碱([3H]ACh)释放的影响。内化pep2-SVKI以阻止GluR2-GRIP/ABP/PICK1相互作用增强了AMPA诱发的[3H]NA释放,但对[3H]ACh释放没有影响。GluR2-PICK1相互作用的阻断剂pep2-AVKI也引起了类似的增强作用。相反,GluR2-NSF相互作用的选择性阻断剂pep2m导致AMPA诱发的[3H]NA释放减少,但对[3H]ACh释放没有影响。在pep2-SVKI存在的情况下,去甲肾上腺素能终末上的突触前AMPARs对环噻嗪失去敏感性。释放[3H]ACh的AMPARs对精胺敏感,而释放[3H]NA的AMPARs则不敏感,这表明它们是缺乏GluR2的AMPARs。综上所述:(i)调节释放的突触前AMPARs在分离的神经终末中持续循环;(ii)该过程具有神经元选择性;(iii)AMPAR的运输和脱敏可能相互关联。